Results 131 to 140 of about 4,900 (222)

Reporting of harms in systematic reviews focused on naltrexone: a cross-sectional study. [PDF]

Front Psychiatry
Schnitker J, Purcell L, Garrett M, Flores H, Wise A, Kee M, Rucker B, Khan A, Beaman J, Vassar M.   +9 more
europepmc   +1 more source

Co-administration of low-dose-Naltrexone and Carbamazepine remarkedly ameliorate allodynia and cognitive deficit in a rat model of trigeminal neuralgia. [PDF]

Sci Rep
Naderi Y, Soti M, Soltani M, Naderi Y, Kohlmeier KA, Shabani M.   +5 more
europepmc   +1 more source

Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone [PDF]

, 2007
Gayatri Sathyan, Emily Xu, John Thipphawong, Suneel K Gupta   +3 more
core   +1 more source

The Effectivity and Safety of Naltrexone/Bupropion in Patients Suffering from Overweight and Obesity in a Real-World Setting. [PDF]

Obes Facts
Jense M, Jense MTF, Knibbeler L, Hoogma RPLM, Palm-Meinders IH, Greve JWM, Boerma EG.   +6 more
europepmc   +1 more source

Design and Characterisation of Niosomes for Ocular Delivery of Naltrexone Hydrochloride

, 2011
Hamdy Abdelkader
openalex   +1 more source

A Review of Alpha-2 Adrenergic Agents Implicated in Opioid Use Disorder. [PDF]

ACS Chem Neurosci
Hannum A, Spano I, Ofori E.
europepmc   +1 more source

Naltrexone hydrochloride use in the treatment of alcoholism.

, 1996
Stankevich Ey
openalex   +1 more source

Subjective Olfactory Impairment in a Patient Undergoing Anti-Obesity Pharmacotherapy: A Case of Symptom-Test Discrepancy. [PDF]

Life (Basel)
Lee HJ, Min HJ.
europepmc   +1 more source

Predicting individual treatment response in alcohol use disorders: a reverse translational proof-of-concept study. [PDF]

Transl Psychiatry
De Carlo S, Mrizak H, Della Valle A, Lunerti V, Kyratzi MO, Mammone A, Lacorte A, Keshishian A, Li M, Domi E, Qin D, Woods LS, Soverchia L, Ubaldi M, Ciccocioppo R, Cannella N.   +15 more
europepmc   +1 more source

Mechanistic Insights into G Protein-Biased κ-Opioid Receptor Signaling Using Dual-Charged Naltrexamine Amides. [PDF]

J Med Chem
Doering NP, Puls K, Diceglie M, Meraner A, Hentsch A, Hongnak S, Wurzer A, Schmidhammer H, Spetea M, Nazare M, Wolber G.   +10 more
europepmc   +1 more source